Risperidone-SABER® Disease area studied Abbreviated title Phase Study ID Registry database Study results Plain language summary Publication (if available) Schizophrenia A Safety and PK Study of Injectable Risperidone-SABER and the DosePro Delivery System in Patients With Schizophrenia Phase 1 ZX003-1101 Completed NCT01592110 Schizophrenia Safety and PK Trial With Injectable ZX003 (Risperidone-SABER®) Compared to Risperdal® Consta® in Stable Schizophrenia Phase 1 ZX003-1401 Completed NCT02411526
